Vinflunine

4 trials 1 recruiting LOncology

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

1 Recruiting

3 Completed trials

4 Sponsors

10 Countries

Phase III

Phase III: 4

Indications tested

Bladder cancer 1

Sponsors using this IMP

Astellas Pharma Global Development Inc. 1 Gilead Sciences Inc. 1 Janssen - Cilag International 1 Merck Sharp & Dohme LLC 1

All trials

4 total

A clinical trial of sacituzumab tirumotecan to treat urothelial cancer (MK-2870-031) Recruiting

2024-520014-22-00 Phase III 8 countries Merck Sharp & Dohme LLC
A Randomized Open-Label Phase III Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Subjects With Metastatic or Local… Ended

2024-513870-23-00 Phase III 8 countries Gilead Sciences Inc.
A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelia… Ended

2024-517571-20-00 Phase III 2 countries Astellas Pharma Global Development Inc.
A Study of Erdafitinib Compared with Vinflunine or Docetaxel or Pembrolizumab in Subjects with Urothelial Cancer Ended

2023-510296-56-00 Phase III 3 countries Janssen Cilag International

Showing 1–4 of 4 trials

← All drugs A–Z